Polypeptide compound aiming at SORT1 and drug conjugate thereof
The present invention relates to a targeting peptide specifically targeting a Sortiin/SORT1 protein, and a targeting peptide-drug conjugate comprising the targeting peptide. The targeting peptide is linear peptide or cyclic peptide containing non-natural chemical modification, and the half-life peri...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a targeting peptide specifically targeting a Sortiin/SORT1 protein, and a targeting peptide-drug conjugate comprising the targeting peptide. The targeting peptide is linear peptide or cyclic peptide containing non-natural chemical modification, and the half-life period of the targeting peptide-drug conjugate can be prolonged, and the stability of the targeting peptide-drug conjugate can be improved. The targeting peptide-drug conjugate can be specifically combined with target protein Sortiin/SORT1 with high affinity, so that tumors expressing Sortiin/SORT1 are efficiently killed, and a novel anti-tumor targeting drug is provided for the field of tumor treatment.
一种特异性靶向Sortilin/SORT1蛋白的靶向肽,以及包含所述靶向肽的靶向肽-药物偶联物。该靶向肽为含非天然化学修饰的线性肽或环肽,可以改善靶向肽-药物偶联物的半衰期并提高其稳定性。靶向肽-药物偶联物能够以高亲和力特异性结合靶蛋白Sortilin/SORT1,从而高效杀伤表达Sortilin/SORT1的肿瘤,为肿瘤治疗领域提供了一种新型抗肿瘤靶向药。 |
---|